CANBRIDGE PHARM.DL-00001 (MF1) — Cash Flow-to-Debt Ratio
CANBRIDGE PHARM.DL-00001 (MF1) has a Cash Flow-to-Debt Ratio of -0.08x as of December 2025, meaning its operating cash flow of €-38.21 Million could theoretically repay 0% of its total liabilities (€507.15 Million) in one year. See MF1 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
CANBRIDGE PHARM.DL-00001 Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for CANBRIDGE PHARM.DL-00001 across 5 annual periods. Also explore MF1 net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for CANBRIDGE PHARM.DL-00001 (2021–2025)
Year-by-year debt coverage analysis for CANBRIDGE PHARM.DL-00001. For market capitalisation and broader financial context, see CANBRIDGE PHARM.DL-00001 (MF1) total market value.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.08x | €-38.21 Million | €507.15 Million | ▲ +63.6% |
| 2024 | -0.21x | €-122.39 Million | €591.30 Million | ▲ +67.6% |
| 2023 | -0.64x | €-278.23 Million | €435.15 Million | ▲ +10.5% |
| 2022 | -0.71x | €-280.98 Million | €393.49 Million | ▲ +75.8% |
| 2021 | -2.95x | €-587.07 Million | €199.13 Million | — |